| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/05/2013 | US8389802 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
| 03/05/2013 | US8389791 Treatment devices and methods with extending elements |
| 03/05/2013 | US8389695 Selenium containing modifying agents and conjugates |
| 03/05/2013 | US8389690 Antibodies to JTT-1 protein and cells secreting such antibodies |
| 03/05/2013 | US8389686 Noncovalent collagen crosslinking agent |
| 03/05/2013 | US8389680 Treatment of Aspergillus infections with alpha thymosin peptides |
| 03/05/2013 | US8389678 Protein fragments of virB10 and sero-detection of Anaplasma phagocytophilum |
| 03/05/2013 | US8389676 Biotinylation tag peptides |
| 03/05/2013 | US8389675 PMMA binding peptides |
| 03/05/2013 | US8389496 Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma |
| 03/05/2013 | US8389494 p185neu-encoding DNA and therapeutical uses thereof |
| 03/05/2013 | US8389491 Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same |
| 03/05/2013 | US8389482 Short peptides useful for treatment of ischemia/reperfusion injury and other tissue damage conditions associated with nitric oxide and its reactive species |
| 03/05/2013 | US8389481 Glutamate-enhanced cell-penetrating peptides and methods of using same |
| 03/05/2013 | US8389480 G protein coupled receptor agonists and antagonists and methods of activating and inhibiting G protein coupled receptors using the same |
| 03/05/2013 | US8389479 Compositions and methods for treatment of multiple sclerosis |
| 03/05/2013 | US8389478 Methods and compositions for treating neurodegenerative disorders and Alzheimer's disease and improving normal memory |
| 03/05/2013 | US8389477 Amylin and amylin agonists for treating psychiatric diseases and disorders |
| 03/05/2013 | US8389476 Parstatin peptides and uses thereof |
| 03/05/2013 | US8389475 Relaxin analogs |
| 03/05/2013 | US8389474 Rationale for IL-1 β targeted therapy to improve harvested organ viability, allograft tolerance, replant success and for conditions characterized by reduced or absent arterial perfusion |
| 03/05/2013 | US8389473 Treatment of cardiac arrhythmias |
| 03/05/2013 | US8389472 Exendin-4 to treat nonalcoholic steatohepatitis and nonalcoholic fatty liver disease |
| 03/05/2013 | US8389471 Amino acid composition for improving glucose tolerance |
| 03/05/2013 | US8389470 Methods and compositions for delivering peptides |
| 03/05/2013 | US8389469 Bacteriophage lysins for Bacillus anthracis |
| 03/05/2013 | US8389468 Approach to the treatment of compartment syndrome |
| 03/05/2013 | US8389467 In situ self-setting mineral-polymer hybrid materials, composition and use thereof |
| 03/05/2013 | US8389262 Subtilase variants having altered immunogenicity |
| 03/05/2013 | US8389261 Method of isolation and purification of trypsin from pronase protease and use thereof |
| 03/05/2013 | US8389244 Methods and kits for synthesis of siRNA expression cassettes |
| 03/05/2013 | US8389228 Process for the measurement of the potency of glatiramer acetate |
| 03/05/2013 | US8389005 Systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance |
| 03/05/2013 | US8389003 Ingestible implement for weight control |
| 03/05/2013 | US8388975 Cancer antigen peptides derived from WT1 |
| 03/05/2013 | US8388963 Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof |
| 03/05/2013 | US8388962 Molecules and methods of using same for treating MCP-1/CCR2 associated diseases |
| 03/05/2013 | US8388957 Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors |
| 03/05/2013 | US8388953 Method of increasing cathepsin B-induced cleavage of amyloid-β peptides |
| 03/05/2013 | US8388952 Treating cholinergically-influenced disorders using mixtures comprising extracellular matrix digesting enzyme and botulinum toxin |
| 03/05/2013 | US8388951 Method for treating systemic DNA mutation disease |
| 03/05/2013 | US8388950 Coenzyme Q10-containing water-soluble composition and process for production thereof |
| 03/05/2013 | US8388949 Compositions comprising pantothenic acid and their use for stimulating appetite |
| 03/05/2013 | US8388942 Methods of interferon-β purification and recovery |
| 03/05/2013 | US8388935 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 03/05/2013 | US8388933 Multimeric protein toxins to target cells having multiple identifying characteristics |
| 03/05/2013 | CA2579119C Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan |
| 03/05/2013 | CA2578250C Therapeutic composition with a botulinum neurotoxin |
| 03/05/2013 | CA2545034C Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices |
| 03/05/2013 | CA2539033C Treatment of disease or injury of the nervous system with fty720 |
| 03/05/2013 | CA2335340C Fsh and fsh variant formulations, products and methods |
| 02/28/2013 | WO2013029062A1 Peginterferon lambda 1 conjugates, processes for their preparation, pharmaceutical compositions containing these conjugates and processes for making the same |
| 02/28/2013 | WO2013029011A2 Methods and compositions comprising a c-terminal bax peptide |
| 02/28/2013 | WO2013028740A1 Compositions and methods for treating inflammation |
| 02/28/2013 | WO2013028658A1 Method for preventing or treating a bacterial infection |
| 02/28/2013 | WO2013028615A2 Novel cyclosporin derivatives for the treatment and prevention of viral infections |
| 02/28/2013 | WO2013028555A2 Methods for weight loss and ketogenic compositions |
| 02/28/2013 | WO2013028541A1 Vegf-binding protein for blockade of angiogenesis |
| 02/28/2013 | WO2013028465A1 Crystal forms of a hcv protease inhibitor |
| 02/28/2013 | WO2013028137A1 A protein involved in detection of cancer metastasis and a treatment thereof |
| 02/28/2013 | WO2013028070A2 Compounds for use in boosting coagulation |
| 02/28/2013 | WO2013027911A1 Composition for treatment or prevention of erectile dysfunction including dkk2 protein or dkk2 gene thereof and use of the composition |
| 02/28/2013 | WO2013027680A1 Drug for preventing exacerbation of malignant tumor, comprising combination of natriuretic peptide receptor gc-a agonist and gc-b agonist |
| 02/28/2013 | WO2013027658A1 Cartilage/bone destruction suppressor |
| 02/28/2013 | WO2013027217A1 Zymoxins and methods of using the same |
| 02/28/2013 | WO2013027191A1 Methods and compositions using fgf23 fusion polypeptides |
| 02/28/2013 | WO2013026942A1 Tubulin binding agents |
| 02/28/2013 | WO2013026927A1 Potent ligands of the ghrelin receptor |
| 02/28/2013 | WO2013026913A2 Means and methods for treating angiogenesis-related diseases |
| 02/28/2013 | WO2013026896A1 Peptide agent for enhanced drug delivery for improved peripheral analgesia |
| 02/28/2013 | WO2013026794A1 Novel immunomodulatory peptide |
| 02/28/2013 | WO2013026334A1 Cell dna synthesis prevention and cell proliferation inhibition polypeptide and use thereof |
| 02/28/2013 | WO2013026157A1 Anti-cancer peptides and uses thereof |
| 02/28/2013 | WO2013026089A1 Peptides for use in the treatment of il-1 related diseases and conditions |
| 02/28/2013 | WO2013000922A9 Ccr2 antagonist peptides |
| 02/28/2013 | WO2012178078A3 Use of yscf, truncated yscf and yscf homologs as adjuvants |
| 02/28/2013 | WO2012178033A3 Serpina1 sirnas: compositions of matter and methods of treatment |
| 02/28/2013 | WO2012175745A9 Cell secreted proteins for the treatment of myocardial infarction |
| 02/28/2013 | WO2012174480A3 Continuous subcutaneous insulin infusion methods with a hyaluronan degrading enzyme |
| 02/28/2013 | WO2012174397A3 Anti-inflammatory pharmaceutical products |
| 02/28/2013 | WO2012167109A9 Rpgrip1 gene therapy for leber congenital amaurosis |
| 02/28/2013 | WO2012166705A3 Supramolecular nanofibers and hydrogels based on amino acid-nucleobase-glycoside conjugates |
| 02/28/2013 | WO2012166611A3 Methods for treating and preventing neutrophil-derived net toxicity and thrombosis |
| 02/28/2013 | WO2012166006A9 Protein-polypeptide complex with a specific effect on skin tissue, method for producing said complex and pharmaceutical composition on the basis thereof |
| 02/28/2013 | WO2012162637A3 Vaccine adjuvants from self-assembling peptides |
| 02/28/2013 | WO2012162342A3 Influenza vaccines containing modified adenovirus vectors |
| 02/28/2013 | WO2012158960A3 Melanocortin 1 receptor ligands and methods of use |
| 02/28/2013 | WO2012145509A3 Adeno-associated-virus rep sequences, vectors, and viruses |
| 02/28/2013 | WO2012142434A3 Aav mediated ctla-4 gene transfer to treat sjogren's syndrome |
| 02/28/2013 | WO2012116253A3 Recombinant mumps virus vaccine |
| 02/28/2013 | US20130053330 Fertilization Prediction and Promotion |
| 02/28/2013 | US20130053329 Methods of inhibiting apoptosis or inflammation in a mammal by administering an isolated bcl protein |
| 02/28/2013 | US20130053328 Compositions and methods of inhibiting photoreceptor apoptosis |
| 02/28/2013 | US20130053327 Polypeptide expressed in the stratum corneum and use thereof |
| 02/28/2013 | US20130053326 Method of treating sexual dysfunctions with delta opioid receptor agonist compounds |
| 02/28/2013 | US20130053325 Secondary Structure Stabilized NMDA Receptor Modulators and Uses Thereof |
| 02/28/2013 | US20130053324 Novel self-assembling peptides and their use in the formation of hydrogels |
| 02/28/2013 | US20130053323 Methods and use related to humanin and humanin-like peptides |
| 02/28/2013 | US20130053322 Hsa-related compositions and methods of use |
| 02/28/2013 | US20130053321 Inhibitors of mitochondrial fission and methods of use thereof |